Forbion Ventures
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Pre-Seed, Seed, Early Stage, Series A, Series B, Growth, Late Stage, Pre-IPO
Geographical Focus
United States, United Kingdom, Germany, France, Italy, Denmark, Switzerland, Spain, Luxembourg, Ireland, Austria, Netherlands, Portugal, Sweden, Belgium, Norway, Finland, Poland, Czech Republic, Slovakia
Industries Focus
- Healthcare
- Agriculture
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Food Technology
- Biotechnology
- Oncology
- Neurology
- Cardiology
- Materials Science
- Immunology
- Genomics
- Sustainable Energy
- Environmental Technologies
Investment Size:
1,500,000 to 30,000,000 USD
Investor Details Founded: 1990
Forbion Ventures is a prominent global venture capital firm specializing in the life sciences sector, with a strong presence in Europe. The firm manages approximately €5 billion across multiple fund strategies, covering all stages of (bio-)pharmaceutical drug development. In addition to its focus on human health, Forbion Ventures addresses planetary health challenges through its BioEconomy fund strategy, investing in companies developing sustainable solutions in food, agriculture, materials, and environmental technologies.
The firm's team comprises over 30 investment professionals who have built an impressive performance track record since the late nineties, with 128 investments across 11 funds. Forbion Ventures operates a joint venture with BGV, the manager of seed and early-stage funds, especially focused on the Benelux and Germany regions.
Forbion Ventures has a strong track record of sourcing, building, and guiding life sciences companies, resulting in numerous approved therapies and successful exits. The firm selects impactful investments that positively affect the health and well-being of people and the planet, while meeting its financial return objectives. Forbion Ventures is a signatory to the United Nations Principles for Responsible Investment, reflecting its commitment to responsible and sustainable investing.
Requirements
- Innovative biotech companies
- Focus on human health and planetary health
- Sustainable solutions in food, agriculture, materials, and environmental technologies
- Companies at all stages of pharmaceutical drug development
- Alignment with United Nations Principles for Responsible Investment
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Azafaros
- VectorY
- Genomines
- Noema Pharma
- Braveheart Bio
- AAVantgarde Bio
- EEDEN GmbH
Mentioned In
-
$24.95
-
$49.95
-
$19.95
-
$19.95
-
$19.95
-
$24.95
-
$99.00
Claim this Investor
Are you an official representative of Forbion Ventures?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim